BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.770
-0.020 (-1.12%)
At close: Jun 12, 2025, 4:00 PM
1.840
+0.070 (3.95%)
After-hours: Jun 12, 2025, 7:57 PM EDT
BTAI's stock price has decreased by -92.26% in the past year and price targets may not have had time to catch up.
BioXcel Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$42.60
Upside
+2,306.78%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +3,572.32% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $48 | Strong Buy | Maintains | $80 → $48 | +2,611.86% | Jan 30, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $112 → $4 | Strong Buy → Sell | Downgrades | $112 → $4 | +125.99% | Jan 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $112 → $80 | Strong Buy | Maintains | $112 → $80 | +4,419.77% | Jan 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $112 → $80 | Strong Buy | Maintains | $112 → $80 | +4,419.77% | Oct 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $112 | Strong Buy | Reiterates | $112 | +6,227.68% | Sep 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $112 | Strong Buy | Maintains | $112 | +6,227.68% | Aug 30, 2024 |
| UBS | UBS | Hold Maintains $56 → $16 | Hold | Maintains | $56 → $16 | +803.95% | Aug 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $160 → $112 | Strong Buy | Maintains | $160 → $112 | +6,227.68% | Aug 8, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $112 | Strong Buy | Maintains | $112 | +6,227.68% | Jun 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +8,939.55% | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +8,939.55% | Apr 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $176 | Strong Buy | Reiterates | $176 | +9,843.50% | Mar 18, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $288 → $112 | Strong Buy | Maintains | $288 → $112 | +6,227.68% | Mar 14, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $128 → $112 | Strong Buy | Maintains | $128 → $112 | +6,227.68% | Mar 13, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $144 → $64 | Strong Buy → Hold | Downgrades | $144 → $64 | +3,515.82% | Feb 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.